.

.


LogOff Samples
The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.
    Letters in applied microbiology (Lett Appl Microbiol ) Vol: 26 Issue 5 Pages: 333-7
    Pub: 1998 May Epub:
    • Charteris WP
    • Kelly PM
    • Morelli L
    • Collins JK

  2. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases (Braz J Infect Dis ) Vol: 4 Issue 5 Pages: 236-44
    Pub: 2000 Oct Epub:
    • Mendes C
    • Hsiung A
    • Kiffer C
    • Oplustil C
    • Sinto S
    • Mimica I
    • Zoccoli C
    • Mystic Study Group.

  3. Multi-drug resistant gram-negative enteric bacteria isolated from flies at Chengdu Airport, China.
    The Southeast Asian journal of tropical medicine and public health (Southeast Asian J Trop Med Public Health ) Vol: 44 Issue 6 Pages: 988-96
    Pub: 2013 Nov Epub:
    • Liu Y
    • Yang Y
    • Zhao F
    • Fan X
    • Zhong W
    • Qiao D
    • Cao Y

  4. Extensive impact of non-antibiotic drugs on human gut bacteria.
    Nature (Nature ) Vol: 555 Issue 7698 Pages: 623-628
    Pub: 2018 Mar 29 Epub: 2018 Mar 19
    • Maier L
    • Pruteanu M
    • Kuhn M
    • Zeller G
    • Telzerow A
    • Anderson EE
    • Brochado AR
    • Fernandez KC
    • Dose H
    • Mori H
    • Patil KR
    • Bork P
    • Typas A

  5. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Diagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis ) Vol: 47 Issue 3 Pages: 527-37
    Pub: 2003 Nov Epub:
    • Casellas JM
    • Tomé G
    • Bantar C
    • Bertolini P
    • Blázquez N
    • Borda N
    • Couto E
    • Cudmani N
    • Guerrera J
    • Juárez MJ
    • López T
    • Littvik A
    • Méndez E
    • Notario R
    • Ponce G
    • Quinteros M
    • Salamone F
    • Sparo M
    • Sutich E
    • Vaylet S
    • Wolff L

  6. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Journal of hepatology (J Hepatol ) Vol: 60 Issue 4 Pages: 824-31
    Pub: 2014 Apr Epub: 2013 Dec 6
    • Vrieze A
    • Out C
    • Fuentes S
    • Jonker L
    • Reuling I
    • Kootte RS
    • van Nood E
    • Holleman F
    • Knaapen M
    • Romijn JA
    • Soeters MR
    • Blaak EE
    • Dallinga-Thie GM
    • Reijnders D
    • Ackermans MT
    • Serlie MJ
    • Knop FK
    • Holst JJ
    • van der Ley C
    • Kema IP
    • Zoetendal EG
    • de Vos WM
    • Hoekstra JB
    • Stroes ES
    • Groen AK
    • Nieuwdorp M

  7. Antimicrobial activity and antibiotic susceptibility of <i>Lactobacillus</i> and <i>Bifidobacterium</i> spp. intended for use as starter and probiotic cultures.
    Biotechnology, biotechnological equipment (Biotechnol Biotechnol Equip ) Vol: 29 Issue 1 Pages: 84-91
    Pub: 2015 Jan 2 Epub: 2014 Dec 11
    • Georgieva R
    • Yocheva L
    • Tserovska L
    • Zhelezova G
    • Stefanova N
    • Atanasova A
    • Danguleva A
    • Ivanova G
    • Karapetkov N
    • Rumyan N
    • Karaivanova E

  8. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect ) Vol: 50 Issue 6 Pages: 879-885
    Pub: 2017 Dec Epub: 2016 Dec 18
    • Chiu CC
    • Lin TC
    • Wu RX
    • Yang YS
    • Hsiao PJ
    • Lee Y
    • Lin JC
    • Chang FY

  9. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.
    Microbiology (Reading, England) (Microbiology ) Vol: 156 Issue Pt 11 Pages: 3354-9
    Pub: 2010 Nov Epub: 2010 Aug 19
    • Tannock GW
    • Munro K
    • Taylor C
    • Lawley B
    • Young W
    • Byrne B
    • Emery J
    • Louie T

  10. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 53 Issue 6 Pages: 1018-32
    Pub: 2004 Jun Epub: 2004 May 5
    • Reynolds R
    • Potz N
    • Colman M
    • Williams A
    • Livermore D
    • MacGowan A
    • BSAC Extended Working Party on Bacteraemia Resistance Surveillance.

Full list available by paid subscriptions

For More information see this summary.